BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26708891)

  • 21. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia.
    Chen H; Liu KY; Xu LP; Chen YH; Han W; Zhang XH; Wang Y; Qin YZ; Liu YR; Huang XJ
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1110-6. PubMed ID: 25698612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Increased risk of severe acute graft-versus-host disease in low body mass index patients undergoing haploidentical allogeneic stem cell transplantation].
    Chen Y; Xu L; Liu D; Liu K; Chen H; Zhang X; Wang F; Wang J; Wang Y; Han W; Chen Y; Yan C; Zhao T; Huang X
    Zhonghua Nei Ke Za Zhi; 2014 Sep; 53(9):710-4. PubMed ID: 25511404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salvage therapy for acute chemorefractory leukemia by allogeneic stem cell transplantation: the Korean experience.
    Yoo SH; Koh Y; Kim DY; Lee JH; Lee JH; Lee KH; Yoon SS; Park S; Park SK; Hong DS; Yi HG; Kim CS; Jang JE; Cheong JW; Moon J; Min YH; Sohn SK; Kim I;
    Ann Hematol; 2017 Apr; 96(4):605-615. PubMed ID: 28091736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical study of allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute lymphocytic leukemia].
    Ma X; Wu DP; Sun AN; Fu ZZ; Tang XW; Wu XJ; Liu YJ; Qiu HY; Miao M; Han Y; Jin ZM; Zhao Y; Xue SL; Wang Y; Chen SN; He GS; Zhou HX; Chang HR
    Zhonghua Xue Ye Xue Za Zhi; 2009 Feb; 30(2):73-6. PubMed ID: 19563014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical Summarization of Allogeneic Hematopoietic Stem Cell Transplantation for Leukemia: A Report of 100 Cases].
    Huang QX; Tu SF; Huang R; Huang YX; Deng L; Wu BY; Song CY; Li YH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):556-61. PubMed ID: 27151029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytogenetic risk stratification may predict allogeneic hematopoietic stem cell transplantation outcomes for chronic myelomonocytic leukemia.
    Motohashi K; Fujisawa S; Doki N; Kobayashi T; Mori T; Usuki K; Tanaka M; Fujiwara S; Kako S; Aoyama Y; Onoda M; Yano S; Gotoh M; Kanamori H; Takahashi S; Okamoto S;
    Leuk Lymphoma; 2018 Jun; 59(6):1332-1337. PubMed ID: 29032731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
    Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L
    Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Impact of Donor Source on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in Adults with Chronic Myelomonocytic Leukemia: A Nationwide Retrospective Analysis in Japan.
    Itonaga H; Aoki K; Aoki J; Ishikawa T; Ishiyama K; Uchida N; Sakura T; Ohashi K; Kurokawa M; Ozawa Y; Matsuoka KI; Nakamura Y; Kimura F; Iwato K; Nawa Y; Hirokawa M; Kato K; Ichinohe T; Atsuta Y; Miyazaki Y
    Biol Blood Marrow Transplant; 2018 Apr; 24(4):840-848. PubMed ID: 29196081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of donor and recipient KIR genes and KIR ligands on the occurrence of acute graft-versus-host disease and graft survival after HLA-identical sibling hematopoietic stem cell transplantation.
    Hoseinian SA; Jafari D; Mahmoodi M; Alimoghaddam K; Ostadali M; Talebzadeh Bonakdar A; Foma AM; Yekaninejad MS; Amirzargar AA
    Turk J Med Sci; 2018 Aug; 48(4):794-804. PubMed ID: 30119155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The clinical analysis of allogeneic hematopoietic stem cell transplantation from human leukocyte antigen-identical siblings in 95 patients with myelodysplastic syndrome].
    Zhao T; Huang X; Liu D; Wang J; Zhang X; Wang Y; Han W; Chen H; Chen Y; Wang F; Liu K; Xu L
    Zhonghua Nei Ke Za Zhi; 2014 Feb; 53(2):89-93. PubMed ID: 24767157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Second allogeneic transplant for leukemia relapsed after first allogeneic transplantation].
    Yang DL; Han MZ; Feng SZ; Wang M; Zou DH; Wei JL; Yan ZS; Zhou SY; Liu QG; Jiang EL; Huang Y; Wang HH; Zhou Z; Zhai WJ; Yan WW; Han ZC
    Zhonghua Xue Ye Xue Za Zhi; 2004 May; 25(5):285-9. PubMed ID: 15182537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia].
    Wang Y; Liu KY; Xu LP; Liu DH; Chen H; Han W; Chen YH; Shi HX; Zhang YC; Wang JZ; Zhang XU; Chen Y; Huang XJ; Lu DP
    Zhonghua Nei Ke Za Zhi; 2007 Nov; 46(11):903-6. PubMed ID: 18261271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allogeneic stem cell transplantation of adult chronic myelomonocytic leukaemia. A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Kröger N; Zabelina T; Guardiola P; Runde V; Sierra J; Van Biezen A; Niederwieser D; Zander AR; De Witte T
    Br J Haematol; 2002 Jul; 118(1):67-73. PubMed ID: 12100129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors on graft-versus-host disease-free and relapse-free survival after allogeneic hematopoietic stem cell transplantation for adults with acute leukemia.
    Tan J; Wang Y; Yu SJ; Ma YY; Lei HY; Liu QF
    Leuk Res; 2017 Aug; 59():1-7. PubMed ID: 28527401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapeutic efficacy of allogeneic hematopoietic stem cell transplantation in children with chronic myelogenous leukemia].
    Jiang H; Hu WT; Chen J; Luo CY; Wang JM; Zhou M; Ye QD; Tang YJ; Luo CJ
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jan; 15(1):19-24. PubMed ID: 23336162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of unrelated cord blood transplantation and HLA-matched sibling hematopoietic stem cell transplantation for patients with chronic myeloid leukemia in advanced stage.
    Zheng C; Tang B; Yao W; Tong J; Zhu X; Song K; Geng L; Liu H; Sun Z
    Biol Blood Marrow Transplant; 2013 Dec; 19(12):1708-12. PubMed ID: 24060407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term outcomes of HLA-matched sibling compared with mismatched related and unrelated donor hematopoietic stem cell transplantation for chronic phase chronic myelogenous leukemia: a single institution experience in China.
    Liu QF; Xu XJ; Chen YK; Sun J; Zhang Y; Fan ZP; Xu D; Jiang QL; Wei YQ; Huang F; Feng R; Liu XL; Xu B; Meng FY
    Ann Hematol; 2011 Mar; 90(3):331-41. PubMed ID: 20872002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A comparison of the therapeutic effects between related donor and unrelated donor allogeneic hematopoietic stem cell transplantation in treatment of leukemia].
    Yang K; Liu QF; Fan ZP; Sun J; Xu D; Wei YQ; Zhang Y; Meng FY
    Zhonghua Nei Ke Za Zhi; 2007 Feb; 46(2):135-9. PubMed ID: 17445441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transplantation of related and unrelated umbilical cord blood stem cells in Austria. Austrian Working Party for Stem Cell Transplantation. Austrian Society of Hematology and Oncology.
    Schwinger W; Urban C; Lackner H; Kerbl R; Sovinz P; Gardner H; Peters C; Niederwieser D; Fink FM; Kögler G
    Wien Klin Wochenschr; 1999 May; 111(9):348-53. PubMed ID: 10407995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Onset of ocular graft-versus-host disease symptoms after allogeneic hematopoietic stem cell transplantation.
    Shikari H; Amparo F; Saboo U; Dana R
    Cornea; 2015 Mar; 34(3):243-7. PubMed ID: 25603230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.